Role of Sialidase in Pulmonary Host Defenses and Acute Lung Injury
唾液酸酶在肺宿主防御和急性肺损伤中的作用
基本信息
- 批准号:7477660
- 负责人:
- 金额:$ 45.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcidsAcute Lung InjuryAddressAdherenceAdhesionsAdult Respiratory Distress SyndromeAffectAffinityAlveolarAnimal ModelAspirate substanceBacteriaBindingBlood capillariesBreathingCathepsin GCell AdhesionCell Adhesion MoleculesCell CommunicationCell Surface ReceptorsCell surfaceCellsCessation of lifeChargeComplexConditionCoupledDataDefense MechanismsDiffuseElastasesEmbryoEndopeptidasesEndothelial CellsEndotheliumEnvironmentEpitheliumEquilibriumEventExcisionFree RadicalsGasesGlycoconjugatesHost DefenseHumanICAM1 geneITGAM geneITGB2 geneImmune responseIn VitroInfectionInfiltrationInflammationInflammatoryInjuryInvadedLeadLength of StayLeukocyte ElastaseLeukocyte TraffickingLeukostasisLigandsLungMammalian CellMediatingMediator of activation proteinMicrobeModelingModificationMolecularMusN-Acetylneuraminic AcidNeuraminidaseOrganPECAM1 genePancreatic ElastasePathway interactionsPattern recognition receptorPeptide HydrolasesPeptidesPermeabilityPhosphorylationPrincipal InvestigatorProcessProductionProtein IsoformsProtein OverexpressionProteinsRangeReactive Oxygen SpeciesRegulationRoleSialic AcidsSialyltransferasesSignal TransductionSiteStimulusSurfaceSyndromeTestingTissuesToll-like receptorsTyrosine Phosphorylationbasecadherin 5capillarycollagenasecytokinein vivoin vivo Modelinhibitor/antagonistinterstitialkidney cellkillingslung injurymacromoleculemicrobialmigrationneutrophilnovel therapeuticsprogramsresponserestorationsialylationtoll-like receptor 4trafficking
项目摘要
DESCRIPTION (provided by applicant): Polymorphonuclear leukocytes (PMN) protect the lung against microbial infection; however, an excessive or prolonged influx of PMNs may cause tissue damage. Acute lung injury is characterized by widespread inflammatory changes, including diffuse PMN infiltration, with injury to both lung epithelium and endothelium. We established that the removal of sialyl residues from the surface of PMNs and endothelial cells (EC) by an endogenous PMN sialidase is critical to normal PMN trafficking. Further, we find that desialylation of the Toll-like receptor (TLR) 4 complex enhances LPS-induced cytokine production, while restoration of sialyl residues by sialyltransferases (ST) may restore the basal state. The overall hypothesis to be tested is that sialidases and STs regulate innate immune responses in the lung, and the balance achieved will dictate whether or not the innate immune response develops into acute lung injury. To address this central hypothesis, we propose the following: In Specific Aim 1 we will define which form(s) of PMN sialidase(s) (neul and neu3) regulates adherence to and migration across human lung microvascular EC by overexpression and knockdown of specific neu proteins. In Specific Aim 2 we will define the substrates for PMN sialidase in PMNs and ECs and assess how their sialylation status affects PMN adhesion in vitro and trafficking in vivo. Since PMNs induce signaling cascades in ECs, in Specific Aim 3 we will examine whether an "appropriate" level of PMN sialidase-induced tyrosine phosphorylation of EC proteins opens the EC-EC paracellular pathway sufficiently for transendothelial migration without protein leak, while at levels that exceed this threshold, if there will be loss of EC barrier function. A "two-hit" model of acute lung injury has been proposed whereby a combination of LPS and chemotactic peptide promotes lung injury. In Specific Aim 4, we will examine the role of sialidase in sensitizing the pulmonary vasculature to circulating LPS and lung injury. The molecular mechanism(s) by which desialylation promotes signaling through the TLR4/MD2/CD14 complex will be examined, as well as the ability of STs to downregulate this response. The ability of sialidase inhibitors to reverse acute lung injury will be studied in vivo in a murine model of pulmonary leukostasis. Since inhibitors of sialidase are commercially available, these studies will provide the experimental rationale for testing a new therapeutic approach to the treatment of lung injury.
描述(由申请人提供):多形核白细胞(PMN)保护肺部免受微生物感染;然而,过度或长时间的PMNs流入可能导致组织损伤。急性肺损伤的特征是广泛的炎症改变,包括弥漫性PMN浸润,肺上皮和内皮均受到损伤。我们证实了内源性PMN唾液酸酶从PMN和内皮细胞(EC)表面去除唾液酸残留物对正常的PMN运输至关重要。此外,我们发现toll样受体(TLR) 4复合物的脱氮化可以增强lps诱导的细胞因子产生,而通过唾液基转移酶(ST)恢复唾液基残基可能会恢复基础状态。需要验证的总体假设是唾液酸酶和STs调节肺部的先天免疫反应,其达到的平衡将决定先天免疫反应是否发展为急性肺损伤。为了解决这一中心假设,我们提出以下建议:在Specific Aim 1中,我们将定义哪种形式的PMN唾液酸酶(neul和neu3)通过过度表达和敲低特定的新蛋白来调节对人肺微血管EC的粘附和迁移。在Specific Aim 2中,我们将定义PMN唾液酸酶在PMN和ECs中的底物,并评估它们的唾液酸化状态如何影响PMN在体外的粘附和体内的转运。由于PMN在EC中诱导信号级联,在Specific Aim 3中,我们将研究是否“适当”水平的PMN唾液酸酶诱导EC蛋白的酪氨酸磷酸化足以打开EC-EC细胞旁通路,以进行跨内皮迁移而不发生蛋白泄漏,而当水平超过这个阈值时,EC屏障功能是否会丧失。提出了一种急性肺损伤的“双击”模型,即LPS和趋化肽的结合促进肺损伤。在特异性目标4中,我们将研究唾液酸酶在肺血管对循环LPS和肺损伤的敏感性中的作用。我们将研究脱氮化促进TLR4/MD2/CD14复合物信号传导的分子机制,以及STs下调这一反应的能力。唾液酸酶抑制剂逆转急性肺损伤的能力将在小鼠肺白斑模型中进行体内研究。由于唾液酸酶抑制剂在商业上是可用的,这些研究将为测试治疗肺损伤的新治疗方法提供实验依据。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alan S. Cross其他文献
Granulocyte Colony-Stimulating Factor Worsens the Outcome of Experimental <em>Klebsiella pneumoniae</em> Pneumonia Through Direct Interaction With the Bacteria
- DOI:
10.1182/blood.v91.7.2525 - 发表时间:
1998-04-01 - 期刊:
- 影响因子:
- 作者:
Thomas K. Held;Martin E.A. Mielke;Marcio Chedid;Matthias Unger;Matthias Trautmann;Dieter Huhn;Alan S. Cross - 通讯作者:
Alan S. Cross
Inflammatory cytokines produced in response to experimental human gonorrhea.
针对实验性人类淋病而产生的炎症细胞因子。
- DOI:
10.1093/infdis/172.1.186 - 发表时间:
1995 - 期刊:
- 影响因子:0
- 作者:
Kyle H. Ramsey;Herman Schneider;Alan S. Cross;John W. Boslego;David L. Hoover;Terri L. Staley;Robert A. Kuschner;Carolyn D. Deal - 通讯作者:
Carolyn D. Deal
86 : IFN-<em>γ</em>, ER-stress, autophagy and antimicrobial defense: A novel ATF6/C/EBP-<em>β</em> centric signaling pathway
- DOI:
10.1016/j.cyto.2013.06.089 - 发表时间:
2013-09-01 - 期刊:
- 影响因子:
- 作者:
Padmaja Gade;Srikatha Belagihalli;Girish Ramachandran;Alan S. Cross;Kazutoshi Mori;Dhan V. Kalvakolanu - 通讯作者:
Dhan V. Kalvakolanu
Health of the public. The academic response. Health of the Public Mission Statement Working Group.
公众的健康。
- DOI:
- 发表时间:
1992 - 期刊:
- 影响因子:0
- 作者:
Jonathan Showstack;Oliver Fein;Daniel E. Ford;Arthur Kaufman;Alan S. Cross;Morton A. Madoff;Harold I. Goldberg;Edward O'Neil;Gordon T. Moore;Steven A. Schroeder - 通讯作者:
Steven A. Schroeder
Bacterial lipopolysaccharide (LPS)‐specific antibodies in commercial human immunoglobulin preparations: superior antibody content of an IgM‐enriched product
商业人免疫球蛋白制剂中的细菌脂多糖 (LPS) 特异性抗体:富含 IgM 的产品具有优异的抗体含量
- DOI:
- 发表时间:
1998 - 期刊:
- 影响因子:4.6
- 作者:
Matthias Trautmann;T. Held;M. Šuša;M. A. Karajan;A. Wulf;Alan S. Cross;Reinhard Marre - 通讯作者:
Reinhard Marre
Alan S. Cross的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alan S. Cross', 18)}}的其他基金
Development of a prototype Klebsiella O polysaccharide conjugate vaccine
克雷伯菌 O 多糖结合疫苗原型的开发
- 批准号:
9089850 - 财政年份:2015
- 资助金额:
$ 45.63万 - 项目类别:
Development of a prototype Klebsiella O polysaccharide conjugate vaccine
克雷伯菌 O 多糖结合疫苗原型的开发
- 批准号:
8841098 - 财政年份:2015
- 资助金额:
$ 45.63万 - 项目类别:
Novel peptide antagonist theraphy for superantigen- induced lethal shock
用于超抗原诱导致死性休克的新型肽拮抗剂疗法
- 批准号:
8233382 - 财政年份:2011
- 资助金额:
$ 45.63万 - 项目类别:
Novel peptide antagonist theraphy for superantigen- induced lethal shock
用于超抗原诱导致死性休克的新型肽拮抗剂疗法
- 批准号:
7670085 - 财政年份:2009
- 资助金额:
$ 45.63万 - 项目类别:
Role of Sialidase in Pulmonary Host Defenses and Acute Lung Injury
唾液酸酶在肺宿主防御和急性肺损伤中的作用
- 批准号:
7637431 - 财政年份:2007
- 资助金额:
$ 45.63万 - 项目类别:
Role of Sialidase in Pulmonary Host Defenses and Acute Lung Injury
唾液酸酶在肺宿主防御和急性肺损伤中的作用
- 批准号:
7866681 - 财政年份:2007
- 资助金额:
$ 45.63万 - 项目类别:
Role of Sialidase in Pulmonary Host Defenses and Acute Lung Injury
唾液酸酶在肺宿主防御和急性肺损伤中的作用
- 批准号:
7318032 - 财政年份:2007
- 资助金额:
$ 45.63万 - 项目类别:
相似国自然基金
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
- 批准号:22007039
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
- 批准号:
- 批准年份:2019
- 资助金额:10.0 万元
- 项目类别:省市级项目
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
- 批准号:21372217
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
- 批准号:21172061
- 批准年份:2011
- 资助金额:30.0 万元
- 项目类别:面上项目
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
- 批准号:21176225
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
- 批准号:81072511
- 批准年份:2010
- 资助金额:31.0 万元
- 项目类别:面上项目
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
- 批准号:30660215
- 批准年份:2006
- 资助金额:21.0 万元
- 项目类别:地区科学基金项目
相似海外基金
CAREER: Highly Rapid and Sensitive Nanomechanoelectrical Detection of Nucleic Acids
职业:高度快速、灵敏的核酸纳米机电检测
- 批准号:
2338857 - 财政年份:2024
- 资助金额:
$ 45.63万 - 项目类别:
Continuing Grant
Lipid nanoparticle-mediated Inhalation delivery of anti-viral nucleic acids
脂质纳米颗粒介导的抗病毒核酸的吸入递送
- 批准号:
502577 - 财政年份:2024
- 资助金额:
$ 45.63万 - 项目类别:
Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
- 批准号:
BB/Y006380/1 - 财政年份:2024
- 资助金额:
$ 45.63万 - 项目类别:
Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
- 批准号:
24K17112 - 财政年份:2024
- 资助金额:
$ 45.63万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
- 批准号:
2300890 - 财政年份:2023
- 资助金额:
$ 45.63万 - 项目类别:
Continuing Grant
Integrated understanding and manipulation of hypoxic cellular functions by artificial nucleic acids with hypoxia-accumulating properties
具有缺氧累积特性的人工核酸对缺氧细胞功能的综合理解和操纵
- 批准号:
23H02086 - 财政年份:2023
- 资助金额:
$ 45.63万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
- 批准号:
23K06918 - 财政年份:2023
- 资助金额:
$ 45.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
- 批准号:
23K05758 - 财政年份:2023
- 资助金额:
$ 45.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
- 批准号:
23K04668 - 财政年份:2023
- 资助金额:
$ 45.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Synthetic analogues based on metabolites of omega-3 fatty acids protect mitochondria in aging hearts
基于 omega-3 脂肪酸代谢物的合成类似物可保护衰老心脏中的线粒体
- 批准号:
477891 - 财政年份:2023
- 资助金额:
$ 45.63万 - 项目类别:
Operating Grants














{{item.name}}会员




